A curated list of prominent venture capital firms actively investing in early-stage health technology companies across Asia. This list covers firms with strong tracks records in digital health, biotech, medtech, and healthcare services, providing founders with key investors who understand the regional regulatory and market dynamics.
Get targeted exposure with custom position pinning and highlighted placement.
A global investment firm with a strong healthcare and technology practice in Asia. They have historically backed transformative healthtech companies by combining deep industry expertise with a platform of operating partners who have built, scaled, and exited successful healthcare businesses across the region.
An early-stage VC firm and accelerator operator that launched the h:ev360 fund specifically for healthcare and life sciences. They provide extensive resources through their incubation program, focusing on digital health, diagnostics, and therapeutics for startups in Asia and globally.
One of the first global VC firms to establish a dedicated China team, Matrix has a significant portfolio in healthcare and technology. They focus on early-stage investments in innovative digital health solutions, medical devices, and biotech companies that are transforming patient care in China.
A leading global venture capital firm with a strong focus on healthcare and consumer tech in China and Asia. They actively invest in early-stage healthtech companies, leveraging their deep network to help startups navigate regulatory landscapes and scale rapidly across Asian markets.
An early-stage venture firm with a strong presence in both China and the US, Gobi has a dedicated healthcare and life sciences practice. They invest in innovative healthtech startups, providing capital and strategic guidance to help companies commercialize new medical technologies and digital health platforms.
While active across stages, Sequoia has a robust healthcare investment team in China that targets early-stage innovators. They focus on digital health, biotech, and medical technology, offering startups access to their extensive network of industry experts and global resources.
A premier investment management firm with significant assets under management in Asia. IDG has a long history of investing in healthcare technology and biotech, supporting early-stage companies with capital, operational support, and strategic partnerships to drive growth in the region.
The corporate venture capital arm of Baidu, focusing on AI, healthcare, and other high-growth sectors in China. They invest in early-stage healthtech startups that leverage artificial intelligence and big data to improve diagnostics, drug discovery, and personalized medicine.
While primarily an e-commerce and digital health platform, its affiliated investment vehicles and ecosystem support early-stage healthtech innovations. They provide startups with access to Alibaba's vast healthcare infrastructure, data capabilities, and customer base for scaling digital health solutions.
Although known for late-stage mega-deals, SoftBank has invested in earlier-stage healthtech companies through its affiliated funds. They provide substantial capital and global reach to ambitious healthtech startups aiming to disrupt traditional healthcare models across Asia and beyond.
A specialized fund family from Fidelity Investments focusing on China and Asian markets. They invest in healthcare technology and biotech companies, providing capital and strategic insights to startups that are leveraging technology to improve healthcare delivery and outcomes.
A leading Chinese investment firm with a significant healthcare practice. Hillhouse invests in early to mid-stage healthtech companies, focusing on innovative therapies, digital health platforms, and medical devices that have the potential to transform the healthcare landscape in Asia.
A prominent early-stage venture capital firm in China with a strong focus on technology and healthcare. They invest in startups that are using internet and AI technologies to revolutionize healthcare services, making them more accessible and efficient for patients.
Founded by Kai-Fu Lee, Sinovation is an early-stage VC firm with a focus on AI and life sciences in China. They invest in healthtech startups that apply artificial intelligence to drug discovery, medical imaging, and personalized healthcare solutions.
A leading global growth investment firm based in Beijing, with a strong focus on healthcare and consumer sectors. They invest in mid to late-stage healthtech companies but also engage with early-stage innovators through their global network and industry expertise.
The venture capital arm of Citigroup, Citi Ventures invests in fintech, healthtech, and other emerging technologies. In Asia, they support early-stage healthtech companies that are building innovative financial or technological solutions to improve healthcare access and efficiency.
Through its venture arm, JPMorgan Chase invests in financial technology and healthcare innovations. They support early-stage healthtech startups that are leveraging technology to streamline healthcare payments, insurance, and administrative processes in Asian markets.
Goldman Sachs' investment arm invests in a diverse range of sectors, including healthcare technology. In Asia, they back early-stage healthtech companies that are developing new digital platforms, medical devices, or biotech solutions with significant growth potential.
Morgan Stanley's venture capital activities include investments in healthcare technology and life sciences. They support early-stage healthtech startups in Asia by providing capital and strategic guidance to help them navigate complex regulatory environments and scale effectively.
UBS's venture capital division invests in innovative technologies, including healthtech. In Asia, they back early-stage companies that are developing new digital health solutions, diagnostic tools, or medical technologies that align with their focus on sustainable and impactful innovation.